Sensei Bio
Erin Colgan has twenty years of experience in the both the accounting and finance fields. Erin joins Sensei Bio from Intarcia Therapeutics where she was the Vice President of FP+A and Commercial Planning, running the annual budgeting process as well as helping the company to prepare for a potential launch of their Type II diabetes product. Prior to Intarcia, Erin held various accounting and finance roles of increasing responsibility over a nine-year career at Vertex Pharmaceuticals, including time spent in the United Kingdom supporting the launch of the company’s CF franchise, overseeing the annual budgeting process, and several years leading the global commercial planning process. Erin began her career in public accounting at PwC where she worked in both audit and business development. Erin holds a bachelor’s degree in accounting from the University of Massachusetts, Amherst.
This person is not in any offices
Sensei Bio
Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.